Cat. No.
MABL-3915
Application
in vivo
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
BIWA‑8
From
Recombinant Antibody
Specificity
The antibody is specific for CD44v6. CD44v6 is a tumor associated antigen abundantly expressed in head and neck squamous cell carcinomas (HNSCC) and in normal squamous epithelium.
Alternative Names
CD44 antigen; CDw44; Epican; Extracellular matrix receptor III; ECMR‑III; GP90 lymphocyte homing/adhesion receptor; HUTCH‑I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycoprotein 1; PGP‑1; Phagocytic glycoprotein I; PGP‑I; BIWA 8
UniProt
P16070
Immunogen
The antibody is the humanized version of the murine BIWA‑1.
Application Notes
The antibody is the mutated version of BIWA‑4 that was constructed with the aim of improving binding affinity. The binding affinity of the antibody to CD44v6 was measured by surface plasmon resonance. The antibody showed a specificity of tumor localization when administrated together with another anti‑CD44v6 antibody to mice in in vivo experiments (Verel et al. 2002; PMID: 11992408). The specificity of the humanized version of the antibody was confirmed by ELISA analysis (Kd=0.84 nM). The antibody had good therapeutic efficacy in in vivo experiments in mice. Mice treated with labelled ¹⁸⁶Re‑BIWA 8 showed a decreased in the tumor volume (US6972324B2).
Antibody First Published
/
Note on publication
/
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


